| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Antiestrogenic activity of DP-TAT-59, an active metabolite of TAT-59 against human breast cancer
|
Toko, T.
|
|
1997
|
39 |
5 |
p. 390-398
|
article
|
| 2 |
Differential toxicity of camptothecin, topotecan and 9-aminocamptothecin to human, canine, and murine myeloid progenitors (CFU-GM) in vitro
|
Erickson-Miller, C. L.
|
|
1997
|
39 |
5 |
p. 467-472
|
article
|
| 3 |
DNA topoisomerase II-dependent cytotoxicity of alkylaminoanthraquinones and their N-oxides
|
Smith, P. J.
|
|
1997
|
39 |
5 |
p. 455-461
|
article
|
| 4 |
Incidence of objectively diagnosed thromboembolic disease in cancer patients undergoing cytotoxic chemotherapy and / or hormonal therapy
|
Shlebak, A. A.
|
|
1997
|
39 |
5 |
p. 462-466
|
article
|
| 5 |
Induction of apoptosis in multi-drug resistant (MDR) human glioblastoma cells by SN-38, a metabolite of the camptothecin derivative CPT-11
|
Nakatsu, Shouji
|
|
1997
|
39 |
5 |
p. 417-423
|
article
|
| 6 |
Modulation of glucuronidation of SN-38, the active metabolite of irinotecan, by valproic acid and phenobarbital
|
Gupta, E.
|
|
1997
|
39 |
5 |
p. 440-444
|
article
|
| 7 |
Optimizing interstitial delivery of BCNU from controlled release polymers for the treatment of brain tumors
|
Sipos, Eric P.
|
|
1997
|
39 |
5 |
p. 383-389
|
article
|
| 8 |
Potentiation of etoposide-induced apoptosis by staurosporine in human tumor cells is associated with events downstream of DNA-protein complex formation
|
Lock, Richard B.
|
|
1997
|
39 |
5 |
p. 399-409
|
article
|
| 9 |
Preclinical trial of doxorubicin entrapped in sterically stabilized liposomes in dogs with spontaneously arising malignant tumors
|
Vail, D. M.
|
|
1997
|
39 |
5 |
p. 410-416
|
article
|
| 10 |
Ras oncogene-transformed and nontransformed cell populations are each heterogeneous but respond differently to the chemotherapeutic drug cytosine arabinoside (Ara-C)
|
Axelrod, D. E.
|
|
1997
|
39 |
5 |
p. 445-451
|
article
|
| 11 |
Superiority of cyclosporin A over PSC-833 in enhancement of VP-16 efficacy in murine tumors in vivo
|
Slater, L. M.
|
|
1997
|
39 |
5 |
p. 452-454
|
article
|
| 12 |
The potential of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide]to circumvent three multidrug-resistance phenotypes in vitro
|
Davey, R. A.
|
|
1997
|
39 |
5 |
p. 424-430
|
article
|
| 13 |
Urinary excretion of ifosfamide, 4-hydroxyifosfamide, 3- and 2-dechloroethylifosfamide, mesna, and dimesna in patients on fractionated intravenous ifosfamide and concomitant mesna therapy
|
Kurowski, V.
|
|
1997
|
39 |
5 |
p. 431-439
|
article
|
Journal description